Literature DB >> 930972

Pelvic exenteration: analysis of 296 patients.

F N Rutledge, J P Smith, J T Wharton, A G O'Quinn.   

Abstract

An analysis of 296 patients who had pelvic exenteration discloses a high risk of postoperative complications and death; however, the safety has been improved by technical modifications for urinary diversion and treatment of the denuded pelvic cavity. Recurrent cancer of the cervix or vagina was the main reason for the operation. Prognostic factors were sought to improve selection of patients who are able to withstand operation, tolerate postoperative complications, and remain free of cancer. The five-year survival rate for 296 patients with various types of cancer calculated by the Berkson-Gage method was 56.5 per cent after death from all causes were deducted, the rate was 42.1 per cent. The five-year survival rate for 196 patients with recurrent carcinoma of the cervix calculated by the Berkson-Gage method was 48.3 per cent; after deaths from all causes were deducted, the rate was 33.8 per cent.

Entities:  

Mesh:

Year:  1977        PMID: 930972     DOI: 10.1016/0002-9378(77)90521-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  20 in total

1.  Perineal hernia repair using permanent suture and mesh: a video case presentation.

Authors:  Andrea M Avondstondt; Dima Ezzedine; Charbel Salamon
Journal:  Int Urogynecol J       Date:  2019-05-28       Impact factor: 2.894

2.  Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.

Authors:  M A Terán-Porcayo; I Zeichner-Gancz; R A C Gomez del-Castillo; A Beltrán-Ortega; G Solorza-Luna
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Tissue expanders: early experience of a novel treatment option for perineal herniation.

Authors:  J M Ali; A Stabler; N R Hall; M Irwin; R Miller; N S Fearnhead
Journal:  Hernia       Date:  2012-06-28       Impact factor: 4.739

4.  Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.

Authors:  T Benn; R A Brooks; Q Zhang; M A Powell; P H Thaker; D G Mutch; I Zighelboim
Journal:  Gynecol Oncol       Date:  2011-03-27       Impact factor: 5.482

Review 5.  Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?

Authors:  L F Williams; C B Huddleston; J L Sawyers; J R Potts; K W Sharp; S W McDougal
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

6.  Central perineal hernia mimicking rectocele: a case report.

Authors:  Dirk Weyhe; Bruno Geier; Orlin Belyaev; Claudia Steinfort; Waldemar Uhl; Volker Zumtobel
Journal:  Langenbecks Arch Surg       Date:  2005-11-01       Impact factor: 3.445

7.  Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.

Authors:  Dariusz Wydra; Janusz Emerich; Sambor Sawicki; Katarzyna Ciach; Andrzej Marciniak
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

8.  Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy?

Authors:  H Patel; J V Joseph; A Amodeo; K Kothari
Journal:  J Minim Access Surg       Date:  2009-10       Impact factor: 1.407

9.  Treatment options in recurrent cervical cancer (Review).

Authors:  Angiolo Gadducci; Roberta Tana; Stefania Cosio; Luca Cionini
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

10.  Overall survival after pelvic exenteration for gynecologic malignancy.

Authors:  Shannon N Westin; Vijayashri Rallapalli; Bryan Fellman; Diana L Urbauer; Navdeep Pal; Michael M Frumovitz; Lois M Ramondetta; Diane C Bodurka; Pedro T Ramirez; Pamela T Soliman
Journal:  Gynecol Oncol       Date:  2014-07-09       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.